Lexaria Bioscience Corp.’s (NASDAQ: LEXX) Upcoming R&D Programs Targeting Global Markets Totaling Over $160 Billion
Lexaria Bioscience plans to launch approximately 12 applied research and development programs in 2022 The programs are designed to explore…